The engineering, construction and real estate sector incorporates activities with enormous relevance and multiplier effects in modern economies, and it is expected that they will play a decisive role in the recovery from the economic crisis resulting from the Covid-19 pandemic.
In a study carried out by EY on the main financial indicators of the largest pharmaceutical companies, a positive evolution in relation to previous years stands out in 2019, with a particular focus on the areas of oncology and immunology, followed by cardiovascular and metabolic diseases.
The energy sector faces an unprecedented level of scrutiny by governments, the media and regulators.
It would have been difficult to believe, on 1 January, that just a few months later, we would be defining this new decade in terms of pre-pandemic, pandemic and post-pandemic.
See more articles